COMMUNIQUÉS West-GlobeNewswire

Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March 2026
24/03/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – DECISIONS OF GENERAL MEETING 24 MARCH 2026 at 16.30 EET Decisions taken by Orion Corporation's Annual General Meeting and Board of Directors' organising meeting on 24 March [...]
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
24/03/2026
IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price. IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade [...]
Adjustment of guidance for 2025/26
24/03/2026
ANNOUNCEMENT NO. 303 24 March 2026 Adjustment of guidance for 2025/26 Over the past period, ChemoMetec's most important market, the North American market for cell and gene therapy, has been affected by three factors [...]
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
24/03/2026
Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography [...]
Leo International Precision Health AG approves cash capital increase excluding subscription rights
24/03/2026
Leo International Precision Health AG / Keyword: Capital measures / Capital increase Leo International Precision Health AG approves cash capital increase excluding subscription rights 24. Mar 2026 / 17:44 CET/CEST [...]
CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer
24/03/2026
Preclinical data demonstrates leronlimab-mediated CCR5 inhibition enhances Temozolomide and radiation response in Glioblastoma Leronlimab demonstrates synergy with standard-of-care therapies, supports plan for [...]
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
24/03/2026
Inflammatory Biomarker Tracking Predicted to Enhance Response to 3-D Bio-Printed Therapies Expands OneTest for Longevity with Chronic Kidney Disease Risk Assessment GAITHERSBURG, Md., March 24, 2026 (GLOBE NEWSWIRE) -- [...]
Earth Science Tech, Inc. (ETST) Launches MyOnlineConsultation.com, Finalizing a Fully Vertically Integrated Telehealth and Pharmacy Ecosystem
24/03/2026
MIAMI, March 24, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified healthcare portfolio, today announced the official launch of [...]
Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
24/03/2026
Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting highly prevalent KRAS [...]
Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
24/03/2026
Fifth Agreement between Propanc & the Universities over a 17yr Period MELBOURNE, Australia, March 24, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical [...]
Enzon Announces Reverse Stock Split
24/03/2026
CRANFORD, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today announced that the previously approved 1-for-100 reverse stock split will become effective [...]
Polyrizon Intends to Acquire up to 20% Stake in Colugo, Developer of Advanced eVTOL Drones for Defense and Urban Air Mobility Applications
24/03/2026
The Company signed a non-binding MOU with shareholders of Colugo. Colugo’s customer include the Israel Defense Forces, national first responders organizations and commercial companies Raanana, Israel, March 24, 2026 ( [...]
Costa Rica Achieves Historic First With Nation’s Inaugural Export of GACP-Certified Medical Cannabis to the European Union
24/03/2026
Hybrida Farms, Costa Rica’s First Dual Licensed Medical Cannabis and Hemp Cultivator, Completes Landmark Shipment Departed March 13, 2026, Setting a New Benchmark for Latin American Pharmaceutical Agriculture CARTAGO, [...]
Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion
24/03/2026
Laupheim (Germany), Milford, MA (USA), March 24, 2026 (GLOBE NEWSWIRE) -- Together We Build: Rentschler Biopharma celebrates Milford site progress and growth since U.S. expansion Milford, Massachusetts site event [...]
ADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as Chief Financial Officer and Chief Business Officer
24/03/2026
– Brings more than 20 years of experience in investment banking advising biotech and other innovative growth companies on financial and corporate development strategy – SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- [...]
Lace-Up Ankle Brace Support Gets Comfort Upgrade and Removable Side Stabilizers
24/03/2026
Lynden, WASHINGTON, March 24, 2026 (GLOBE NEWSWIRE) -- Z Athletics has announced an upcoming updated version of its flagship lace-up ankle brace, featuring upgraded comfort materials and new removable semi-rigid side [...]
Adial Pharmaceuticals Commends Congress on Introduction of Bipartisan Legislation Expanding Access to Emerging AUD Therapies for Veterans
24/03/2026
H.R. 7091 Supports Development of Investigational Treatments for Alcohol Use Disorder and Aligns with Evolving Federal Recovery Standards GLEN ALLEN, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( [...]
Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial
24/03/2026
TORONTO, March 24, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Fraser Health Authority has entered into a Clinical Trial [...]
CenTrak Advances Its RTLS Platform Through Enhanced Healthcare Integrations
24/03/2026
CenTrak receives Epic Toolbox designation and Rauland® VIP Program validation, highlighting interoperable, scalable solutions that streamline clinical workflows and system connectivity NEWTOWN, Pa., March 24, 2026 ( [...]

Pages